{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:44Z","timestamp":1792195244451,"version":"4.4.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T00:00:00Z","timestamp":1500508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0181550","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T13:49:22Z","timestamp":1500558562000},"page":"e0181550","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Effects of pre-surgical administration of prostaglandin analogs on the outcome of trabeculectomy"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8456-7121","authenticated-orcid":true,"given":"Takako","family":"Miki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Kiyoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Shiode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Morizane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Shiraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression","volume":"120","author":"A Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4137\/OED.S4909","article-title":"Clinical options for the reduction of elevated intraocular pressure","volume":"4","author":"L Crawley","year":"2012","journal-title":"Ophthalmol Eye Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/PPA.S4163","article-title":"Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency","volume":"2","author":"S Kulkarni","year":"2008","journal-title":"Patient Preference and Adherence"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4103\/2349-0977.181516","article-title":"Prostaglandin analogs in glaucoma","volume":"2","author":"HS Sethi","year":"2015","journal-title":"Astrocyte"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3466.2006.00001.x","article-title":"Prostanoids in the therapy of glaucoma","volume":"24","author":"N Ishida","year":"2006","journal-title":"Cardiovascular drug reviews"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/OPTH.S6368","article-title":"Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension","volume":"4","author":"M Aihara","year":"2010","journal-title":"Clinical Ophthalmology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/01.opx.0000141791.16683.4a","article-title":"Deepening of lid sulcus from topical bimatoprost therapy","volume":"81","author":"LS Peplinski","year":"2004","journal-title":"Optom Vis Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/IOP.0b013e31817d81df","article-title":"Periobital changes associated with topical bimatoprost","volume":"24","author":"T Filippopoulos","year":"2008","journal-title":"Ophthalmol Plast Reconstr Surg"},{"key":"ref9","first-page":"176","article-title":"Bilateral deepening of upper lid sulcus from topical bimatoprost therapy","volume":"53","author":"JC Yam","year":"2009","journal-title":"J Ocul Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s10384-008-0623-x","article-title":"Deepening of eyelid superior sulcus during topical travoprost treatment","volume":"53","author":"HK Yang","year":"2009","journal-title":"Jpn J Opthalmol"},{"key":"ref11","first-page":"443","article-title":"Orbital fat atrophy in glaucoma patients treated with topical bimatoprost\u2014can bimatoprost cause enophthalmos?","volume":"225","author":"C Tappeiner","year":"2008","journal-title":"Klin Monbl Augenheilkd"},{"key":"ref12","first-page":"332","article-title":"Two cases of deepening of upper lid sulcus from topical bimatoprost therapy","volume":"48","author":"JW Lee","year":"2007","journal-title":"J Korean Ophthalmol Soc"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/15569521003796860","article-title":"Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature","volume":"29","author":"S Aydin","year":"2010","journal-title":"Cutan Ocul Toxicol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/ceo.12163","article-title":"Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost","volume":"42","author":"M Kucukevcilioglu","year":"2014","journal-title":"Clin Experiment Ophthalmol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10384-010-0904-z","article-title":"Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost","volume":"55","author":"J Park","year":"2011","journal-title":"Jpn J Ophthalmol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s10384-011-0075-6","article-title":"Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost","volume":"55","author":"M Aihara","year":"2011","journal-title":"Jpn J Opthalmol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/jop.2011.0160","article-title":"In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes","volume":"28","author":"HY Choi","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jcb.21044","article-title":"Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurin-dependent signaling pathway","volume":"100","author":"L Liu","year":"2007","journal-title":"J Cell Biochem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1210\/endo.137.12.8940395","article-title":"The mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2alpha","volume":"137","author":"CW Miller","year":"1996","journal-title":"Endocrinology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/bbrc.1997.6433","article-title":"Prostaglandin F2alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium","volume":"233","author":"G Serreo","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1167\/iovs.13-12589","article-title":"Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy","volume":"55","author":"Y Taketani","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/IJG.0b013e31824d8d7c","article-title":"Deepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogs","volume":"22","author":"K Inoue","year":"2013","journal-title":"J Glaucoma"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/eye.2014.224","article-title":"Incidence of deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy with a latanoprost ophthalmic solution","volume":"28","author":"R Sakata","year":"2014","journal-title":"Eye"},{"issue":"Suppl1","key":"ref24","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.survophthal.2008.08.004","article-title":"Side effects associated with prostaglandin analog therapy","volume":"53","author":"A Alm","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e61638","DOI":"10.1371\/journal.pone.0061638","article-title":"A cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal features","volume":"8","author":"M Shah","year":"2013","journal-title":"PLoS ONE"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1001\/archopht.1994.01090230051020","article-title":"Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile","volume":"112","author":"DC Broadway","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/archopht.1994.01090230060021","article-title":"Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery","volume":"112","author":"DC Broadway","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1177\/1060028014548569","article-title":"Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension","volume":"48","author":"L Lin","year":"2014","journal-title":"Ann Pharmacother"},{"key":"ref29","first-page":"70","article-title":"PAP: New concerns for prostaglandin use","volume":"19","author":"SJ Berke","year":"2012","journal-title":"Rev Ophthalmol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10384-012-0219-3","article-title":"Recovery from deepening of the upper eyelid sulcus after switching from bimatoprost to latanoprost","volume":"57","author":"R Sakata","year":"2013","journal-title":"Jpn J Ophthalmol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: tha good, the bad and the ugly","volume":"29","author":"C Baudouin","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0161-6420(94)31322-4","article-title":"Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma","volume":"101","author":"C Baudouin","year":"1994","journal-title":"Ophthalmology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1038\/eye.2009.1","article-title":"Topical prostaglandin analogues do not affect selective laser trabeculoplasty outcomes","volume":"23","author":"D Singh","year":"2009","journal-title":"Eye"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1089\/jop.2011.0084","article-title":"The influence of topical prostaglandin analogues in inflammation after selective laser trabeculoplasty treatment","volume":"28","author":"M Ayala","year":"2012","journal-title":"Journal of ocular pharmacology and therapeutics"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2147\/OPTH.S15521","article-title":"Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits","volume":"4","author":"A Ogundele","year":"2010","journal-title":"Clinical Ophthalmology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/jop.2011.0097","article-title":"Comparison of human ocular distribution of bimatoprost and latanoprost","volume":"28","author":"P Ichhpujani","year":"2012","journal-title":"Journal of ocular pharmacology and therapeutics"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0039-6257(02)00302-8","article-title":"Ocular and systemic pharmacokinetics of latanoprost in humans","volume":"47","author":"B Sjoquist","year":"2002","journal-title":"Survey of ophthalmology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0181550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T01:07:25Z","timestamp":1569892045000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0181550"}},"subtitle":[],"editor":[{"given":"Sanjoy","family":"Bhattacharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,20]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0181550","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,20]]}}}